Spirito Italiano Blog

Maliszewski patent medicine flockhart urx284

Estimation of the Total Number of SARS-CoV-2-infected Individuals and the Necessary Tests and Cost during the First Wave of the COVID-19 Pandemic in Japan.
Nawa N, Tebi D, Kuramochi J, Fujiwara T..
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group..
A Cre-driven allele-conditioning line to interrogate CD4+ conventional T cells.
Andrews LP, Vignali KM, Szymczak-Workman AL, Burton AR, Brunazzi EA, Ngiow SF, Harusato A, Sharpe AH, Wherry EJ, Taniuchi I, Workman CJ, Vignali DAA..
. Kanji JN, et al. Vaccine. 2021 Sep 15;39(39):5563-5570. doi: 10.1016/j.vaccine.2021.08.022. Epub 2021 Aug 11. Vaccine. 2021. PMID: 34454782. Rottenstreich M, et al. BJOG. 2021 Sep 23. doi: 10.1111/1471-0528.16941. Online ahead of print. BJOG. 2021. PMID: 34554630. Infect Genet Evol. 2021 Sep 9;95:105079. doi: 10.1016/j.meegid.2021.105079. Online ahead of print. Infect Genet Evol. 2021. PMID: 34509648
.
top
Page
Menu
News
top
Page
Menu
News
Home Print viewSitemap
 
top
Page
Menu
News